Phase 3 study designed with total hip BMD primary endpoint assessed at 12 months, rather than at 24 monthsEB613 single tablet final commercial ...
Nuvation Bio Inc. (NYSE:NUVB) is one of the best cancer stocks to invest in now. On February 9, Nuvation Bio Inc. (NYSE:NUVB) ...
HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio”), a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and ...
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced finalization of a protocol amendment to the ongoing ...
Annovis Bio (ANVS) announced that the FDA has accepted an updated protocol for the pivotal Phase 3 Alzheimer’s Disease study, which is slated to begin in January 2025. In October 2024, the FDA granted ...
Binance Labs has made its first foray into the Decentralized Science (DeSci) sector with an investment in BIO Protocol (BIO), a pioneering platform aimed at transforming early-stage scientific ...
Longevity research is intersecting with crypto through Aubrai, a decentralized science (DeSci) and AI agent launched this week on Base as part of the Bio Protocol. Decentralized science, or DeSci, ...
At 34 degrees Celsius in Maji Moto, Baringo, the searing heat may be uncomfortable for most visitors, but for Joseph Kobetbet, it is something he has long grown accustomed to. For over four decades, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results